MET overexpression correlated with prognosis of EGFR-mutant treatment‑naïve advanced lung adenocarcinoma: a real‑world retrospective study
Clinical and Translational Oncology · 2024
DOI: 10.1007/s12094-024-03391-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Na Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, Hubei, Ch…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-met, ErbB Receptors, Lung Neoplasms, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province, Key Technologies Research and Development Program.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, Hubei, China.
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China.
- Department of Pathology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China.
- Department of Pathology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, 441000, Hubei, China.
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China.
- Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, Hubei, China. fanjun0915@sina.com.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
- Key Technologies Research and Development Program
Zitieren
APA
Wang, N., Zhang, Y., Wu, J., Zhu, Y., Wu, Y., Huang, B., Zhang, R., Fan, J., & Nie, X. (2024). MET overexpression correlated with prognosis of EGFR-mutant treatment‑naïve advanced lung adenocarcinoma: a real‑world retrospective study. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03391-x
Vancouver
Wang N, Zhang Y, Wu J, Zhu Y, Wu Y, Huang B, et al. MET overexpression correlated with prognosis of EGFR-mutant treatment‑naïve advanced lung adenocarcinoma: a real‑world retrospective study. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03391-x
BibTeX
@article{Wang2024,
author = {Wang, Na and Zhang, Yuan and Wu, Junhua and Zhu, Yili and Wu, Ying and Huang, Bo and Zhang, Ruiguang and Fan, Jun and Nie, Xiu},
title = {MET overexpression correlated with prognosis of EGFR-mutant treatment‑naïve advanced lung adenocarcinoma: a real‑world retrospective study},
journal = {Clinical and Translational Oncology},
year = {2024},
doi = {10.1007/s12094-024-03391-x}
}
EUVIMED